Douglas J. Manion - 01 Feb 2023 Form 4 Insider Report for Aclaris Therapeutics, Inc. (ACRS)

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	ACRS	Employee Stock Option (Right to Buy)	Award	$0	+378,000		$0.000000	378,000	01 Feb 2023	Common Stock	378,000	$16.97	Direct	F1
transaction	ACRS	Restricted Stock Units	Award	$0	+108,000		$0.000000	108,000	01 Feb 2023	Common Stock	108,000		Direct	F2, F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Id	Content
F1	Exercisable with respect to 25% of the shares subject to the option vesting in four equal installments on the first, second, third and fourth anniversaries of January 1, 2023, subject to the Continuous Service of the Reporting Person (as defined in the Plan) as of each such date.
F2	Each restricted stock unit represents a contingent right to receive one share of common stock of the issuer.
F3	The shares underlying these restricted stock units vest in four equal installments on the first, second, third and fourth anniversaries of January 1, 2023, subject to the Continuous Service of the Reporting Person (as defined in the Plan) as of each such date.